{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:07:19Z","timestamp":1785550039944,"version":"3.56.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Type 1 diabetes (T1D) is frequently associated with various autoimmune disorders, including gluten-related disorders (GRDs). Early screening for autoantibodies can provide insights into the co-occurrence of these conditions in pediatric patients. This study aims to evaluate the performance of a Point-of-Care Test (POC) BLOT based assay in comparison to the conventional enzyme-linked immunosorbent assay (ELISA) for multiplex autoantibody screening for gluten-related disorders in children with T1D.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cohort of pediatric and adolescent patients diagnosed with T1D was recruited for the study. Both POC-BLOT and ELISA methods were utilized to screen specific autoantibodies associated with GRDs, including anti-gliadin and anti-transglutaminase antibodies. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for both screening methods. Statistical analyses were conducted to compare the results of the two assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 192 participants were included in the study. The overall method agreement between the POC-BLOT and the ELISA test was approximately 90%. The PPV and NPV for both methods were also calculated indicating that the performance of the POC assay was comparable to ELISA. Additionally, results indicated that the POC assay provided faster results, highlighting its potential utility in clinical pediatric settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The POC blot assay demonstrates promising potential as a reliable and rapid screening tool for autoantibodies in pediatric patients with T1D and gluten-related disorders in resource-limited settings. While further validation is needed, these findings suggest that POC testing could facilitate earlier diagnosis and improve the clinical management of coexisting autoimmune conditions in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1648451","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T05:21:12Z","timestamp":1768540872000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Multiplex autoantibody screening in pediatric type 1 diabetes: POC Blot vs. ELISA for gluten-related disorders"],"prefix":"10.3389","volume":"16","author":[{"given":"Adugna","family":"Negussie","sequence":"first","affiliation":[{"name":"Vaccine, Diagnostic and Medical Device Research and Development Directorate, Armauer Hansen Research Institute","place":["Addis Adaba, Ethiopia"]},{"name":"Department of Medical Laboratory Sciences, College of Health Sciences and Medicine, Arsi University","place":["Assela, Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Wusterhausen","sequence":"additional","affiliation":[{"name":"Department of Research and Development, AESKU Diagnostics GmbH & Co. KG","place":["Wendelsheim, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deselegn","family":"Muleta","sequence":"additional","affiliation":[{"name":"Vaccine, Diagnostic and Medical Device Research and Development Directorate, Armauer Hansen Research Institute","place":["Addis Adaba, Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demise","family":"Mulugeta","sequence":"additional","affiliation":[{"name":"Vaccine, Diagnostic and Medical Device Research and Development Directorate, Armauer Hansen Research Institute","place":["Addis Adaba, Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesfin","family":"Bekele","sequence":"additional","affiliation":[{"name":"Adama Public Health Research and Referral Laboratory","place":["Adama, Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Matthias","sequence":"additional","affiliation":[{"name":"AESKU Diagnostics GmbH & Co KG","place":["Wendelsheim, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12916-019-1380-z","article-title":"Celiac disease: A comprehensive current review","volume":"17","author":"Caio","year":"2019","journal-title":"BMC Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/1824-7288-38-10","article-title":"Celiac disease in type 1 diabetes mellitus","volume":"38","author":"Camarca","year":"2012","journal-title":"Ital J Pediatr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13098-022-00897-8","article-title":"Prevalence of haplotype DQ2\/DQ8 and celiac disease in children with type 1 diabetes","volume":"14","author":"Zubkiewicz-Kucharska","year":"2022","journal-title":"Diabetol Metab Syndr"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4291\/wjgp.v8.i2.27","article-title":"Celiac disease: from pathophysiology to treatment","volume":"8","author":"Parzanese","year":"2017","journal-title":"World J Gastrointest Pathophysiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.mam.2014.12.004","article-title":"Immunogenetics of type 1 diabetes mellitus","volume":"42","author":"Morran","year":"2015","journal-title":"Mol Aspects Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-014-0517-x","article-title":"Type 1 diabetes and celiac disease: clinical overlap and new insights into disease pathogenesis","volume":"14","author":"Cohn","year":"2014","journal-title":"Curr Diabetes Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001081","article-title":"Diagnostic accuracy of point of care tests for diagnosing celiac disease: A systematic review and meta-analysis","volume":"53","author":"Singh","year":"2019","journal-title":"J Clin Gastroenterol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s13098-023-01167-x","article-title":"Metabolic control, adherence to the gluten-free diet and quality of life among patients with type 1 diabetes and celiac disease","volume":"15","author":"Al Hayek","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2025-0705","article-title":"Evaluating the performance of a multiparametric igA assay for celiac disease diagnosis","volume":"63","author":"Gambino","year":"2025","journal-title":"Clin Chem Lab Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/26348535221097697","article-title":"Retrospective analysis of a new antigen assay to detect anti-transglutaminase antibodies for diagnosis and monitoring of celiac disease","volume":"16","author":"Verbeke","year":"2022","journal-title":"Plasmatology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"486","DOI":"10.4172\/2155-9899.1000486","article-title":"Comparison of the reliability of 17 celiac disease associated bio-markers to reflect intestinal damage","volume":"8","author":"Lerner","year":"2017","journal-title":"J Clin Cell Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2025.1562073","article-title":"Celiac disease screening in children: evaluating the evidence, benefits, and challenges","volume":"13","author":"Naredi Scherman","year":"2025","journal-title":"Front Pediatr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/cei.13394","article-title":"Antibodies against neo-epitope of microbial and human transglutaminase complexes as biomarkers of childhood celiac disease","volume":"199","author":"Agardh","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1399-543X.2005.00106.x","article-title":"Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes","volume":"6","author":"Krischer","year":"2005","journal-title":"Pediatr Diabetes"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00177-1","article-title":"The natural history of type 1 diabetes: the lancet commission on type 1 diabetes","volume":"10","author":"Ziegler","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-021-05514-3","article-title":"Characteristics of children diagnosed with type 1 diabetes before vs after 6 years of age in the TEDDY cohort study","volume":"64","author":"Krischer","year":"2021","journal-title":"Diabetologia"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2025774","article-title":"The pathogenesis of type 1 diabetes: an updated perspective","volume":"384","author":"Rewers","year":"2021","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/nu12123809","article-title":"Clinical practice: celiac disease","volume":"12","author":"Fasano","year":"2020","journal-title":"Nutrients"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01399","article-title":"Autoimmunity against transglutaminase isotypes: implications for gluten-related disorders and autoimmunity","volume":"8","author":"Lerner","year":"2017","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2012.10.051","article-title":"Neo-epitope tissue transglutaminase autoantibodies as a biomarker of the gluten sensitive skin disease\u2014Dermatitis herpetiformis","volume":"415","author":"Lytton","year":"2013","journal-title":"Clin Chim Acta"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2011.08.006","article-title":"Celiac disease and transglutaminase 2: A model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders","volume":"23","author":"Sollid","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/path.1877","article-title":"The function of immunoglobulin A in immunity","volume":"208","author":"Woof","year":"2006","journal-title":"J Pathol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.14740\/jem507w","article-title":"Serologic screening of celiac disease in patients with type 1 diabetes","volume":"8","author":"Albatayneh","year":"2018","journal-title":"J Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/nu15234926","article-title":"Rapid anti-tTG-igA screening test for early diagnosis of celiac disease in pediatric populations","volume":"15","author":"Mendia","year":"2023","journal-title":"Nutrients"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.5455\/medarh.2014.68.381-383","article-title":"Diagnostic significance of reduced igA in children","volume":"68","author":"Nurkic","year":"2014","journal-title":"Med Arch"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.108293","article-title":"Immunoglobulin A deficiency in children, an undervalued clinical issue","volume":"209","author":"Koenen","year":"2019","journal-title":"Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1648451\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T05:21:13Z","timestamp":1768540873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1648451\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":26,"alternative-id":["10.3389\/fimmu.2025.1648451"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1648451","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"article-number":"1648451"}}